+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID06650488

Comparing Clopidogrel and Aspirin for Cardiovascular Risk Management in Patients with Staphylococcus aureus Bloodstream Infection

Led by Todd C. Lee MD MPH FIDSA · Updated on 2026-09-24

300

Participants Needed

3

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of switching from aspirin to clopidogrel in patients with Staphylococcus aureus bloodstream infections who are already taking aspirin for secondary prevention of cardiovascular events. This open-label randomized controlled trial aims to determine if clopidogrel, which may have activity against S. aureus, can improve outcomes compared to continuing aspirin. This study is a sub-study of the Staphylococcus aureus Network Adaptive Platform SNAP trial and may support a larger Phase 3 trial if the results are positive. Participants will be randomly assigned to one of two groups those who stop aspirin and start clopidogrel without a loading dose, and those who continue their existing aspirin therapy. This comparison will help assess the potential benefits of clopidogrel in managing S. aureus bacteremia while maintaining cardiovascular protection. The study will follow participants up to 90 days after enrollment in the SNAP trial. During the trial, participants will be monitored for outcomes including the Desirability of Outcome Ranking DOOR at day 90, clinical failure, serious adverse events or adverse events leading to discontinuation, mortality, infectious complications, and various cardiovascular and bleeding events. Safety and treatment effects will be carefully assessed throughout the study period. The total duration from enrollment to primary outcome measurement is 90 days.

CONDITIONS

Brief Title

Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia

Research Team

F

Fatima Amari

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here